Loading…
Daniel R. Chevallard is Chief Financial Officer at Lenz Therapeutics. OQRO lists 5 transactions filed with the SEC under this name, the latest on Mar 30, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
5
Companies involved
1
Lenz TherapeuticsLENZ
5 disclosures · Nov 2025 – Mar 2026 · 3 bought
Mar 27, 2026Bought~$64Kdisclosed Mar 30
DetailsOfficial recordJan 2, 202684Kdisclosed Jan 6
DetailsOfficial recordJan 2, 202614Kdisclosed Jan 6
Nov 7, 2025Bought~$50Kdisclosed Nov 8
DetailsOfficial recordNov 7, 2025Bought~$454disclosed Nov 8
DetailsOfficial record